Leahy demands Myriad “march-in rights”

19-07-2013

Leahy demands Myriad “march-in rights”

Senator Patrick Leahy has urged the US National Institutes of Health (NIH) to force Myriad Genetics to license its patents directed to tests for breast and ovarian cancer.


myriad genetics, senator patrick leahy, march-in rights, Bayh-Doyle Act, brca1, brca2

WIPR